Chronic caffeine consumption prevents cognitive decline from young to middle age in rats, and is associated with increased length, branching, and spine density of basal dendrites in CA1 hippocampal neurons

Abstract Chronic caffeine consumption has been inversely associated with the risk of developing dementia and Alzheimer's disease. Here we assessed whether chronic caffeine treatment prevents the behavioral and cognitive decline that male Wistar rats experience from young (≈3 months) to middle a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuroscience 2012-01, Vol.202, p.384-395
Hauptverfasser: Vila-Luna, S, Cabrera-Isidoro, S, Vila-Luna, L, Juárez-Díaz, I, Bata-García, J.L, Alvarez-Cervera, F.J, Zapata-Vázquez, R.E, Arankowsky-Sandoval, G, Heredia-López, F, Flores, G, Góngora-Alfaro, J.L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 395
container_issue
container_start_page 384
container_title Neuroscience
container_volume 202
creator Vila-Luna, S
Cabrera-Isidoro, S
Vila-Luna, L
Juárez-Díaz, I
Bata-García, J.L
Alvarez-Cervera, F.J
Zapata-Vázquez, R.E
Arankowsky-Sandoval, G
Heredia-López, F
Flores, G
Góngora-Alfaro, J.L
description Abstract Chronic caffeine consumption has been inversely associated with the risk of developing dementia and Alzheimer's disease. Here we assessed whether chronic caffeine treatment prevents the behavioral and cognitive decline that male Wistar rats experience from young (≈3 months) to middle age (≈10 months). When animals were young they were evaluated at weekly intervals in three tests: motor activity habituation in the open field (30-min sessions at the same time on consecutive days), continuous spontaneous alternation in the Y-maze (8 min), and elevated plus-maze (5 min). Afterward, rats from the same litter were randomly assigned either to a caffeine-treated group ( n =13) or a control group ( n =11), which received only tap water. Caffeine treatment (5 mg/kg/day) began when animals were ≈4 months old, and lasted for 6 months. Behavioral tests were repeated from day 14 to day 28 after caffeine withdrawal, a time period that is far in excess for the full excretion of a caffeine dose in this species. Thirty days after caffeine discontinuation brains were processed for Golgi-Cox staining. Compared with controls, we found that middle-aged rats that had chronically consumed low doses of caffeine (1) maintained their locomotor habituation during the second consecutive day exposure to the open field (an index of non-associative learning), (2) maintained their exploratory drive to complete the conventional minimum of nine arm visits required to calculate the alternation performance in the Y-maze in a greater proportion, (3) maintained their alternation percentage above chance level (an index of working memory), and (4) did not increase the anxiety indexes assessed by measuring the time spent in the open arms of the elevated plus maze. In addition, morphometric analysis of hippocampal neurons revealed that dendritic branching (90–140 μm from the soma), length of 4th and 5th order branches, total dendritic length, and spine density in distal dendritic branches were greater in the basal but not the apical dendrites of CA1 pyramidal neurons from rats chronically treated with caffeine, in comparison with their age- and littermate-matched controls. Altogether, the present findings strengthen the epidemiological observations suggesting that prolonged caffeine intake prevents the cognitive decline associated with aging, and open the possibility that this process could be mediated by promoting the growth of dendrites and spines in neurons of the adult mammalian brain.
doi_str_mv 10.1016/j.neuroscience.2011.11.053
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_918935037</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0306452211013406</els_id><sourcerecordid>918935037</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-c158a60738522e1ccc7da26149f43729d214fd941f434942fbb9e073ed55e9793</originalsourceid><addsrcrecordid>eNqNkl2rEzEQhhdRPMejf0GCIN6c1iSb7Ha9EA71Ew54oV6HNJltU3eTNZOt9Ef6n0xs_cArQyBM8sxMeN-pqieMLhllzfP90sMcAxoH3sCSU8aWeVNZ36ku2aqtF60U4m51SWvaLITk_KJ6gLineUlR368uOGdS8qa5rL6vdzF4Z4jRfQ_OAzHB4zxOyQVPpggH8Anz5da75A5ALJihYH0MIzmG2W9JCmR01g5A9BaI8yTqhNdEe0scEo0YjNMJLPnm0i6_mwgacziA36bdNdlE7c3O-e0pB6dS34JHl44k9GSjUQ_lwkaXAEuH9Q0jOzdNwehxyo8_BfH4sLrX6wHh0fm8qj6_ef1p_W5x--Ht-_XN7cKIRqSFYXKlG9rWq6wNMGNMazVvmOh6Ube8s5yJ3naC5VB0gvebTQcZBysldG1XX1XPTnWnGL7OgEmNDg0Mg_YQZlQdW3W1pHWbyRcn0mTDMEKvpuhGHY-KUVXcVHv1t5uquKnyzm7m5MfnNvNmBPs79Zd9GXh6BjQaPfRFSId_OCm6TtLCvTpxkEU5OIjq3M66CCYpG9z__eflP2XKLLjc-QscAfdhjj7LrphCrqj6WOavjB_LhWuR__ED6Xvdag</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>918935037</pqid></control><display><type>article</type><title>Chronic caffeine consumption prevents cognitive decline from young to middle age in rats, and is associated with increased length, branching, and spine density of basal dendrites in CA1 hippocampal neurons</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Vila-Luna, S ; Cabrera-Isidoro, S ; Vila-Luna, L ; Juárez-Díaz, I ; Bata-García, J.L ; Alvarez-Cervera, F.J ; Zapata-Vázquez, R.E ; Arankowsky-Sandoval, G ; Heredia-López, F ; Flores, G ; Góngora-Alfaro, J.L</creator><creatorcontrib>Vila-Luna, S ; Cabrera-Isidoro, S ; Vila-Luna, L ; Juárez-Díaz, I ; Bata-García, J.L ; Alvarez-Cervera, F.J ; Zapata-Vázquez, R.E ; Arankowsky-Sandoval, G ; Heredia-López, F ; Flores, G ; Góngora-Alfaro, J.L</creatorcontrib><description>Abstract Chronic caffeine consumption has been inversely associated with the risk of developing dementia and Alzheimer's disease. Here we assessed whether chronic caffeine treatment prevents the behavioral and cognitive decline that male Wistar rats experience from young (≈3 months) to middle age (≈10 months). When animals were young they were evaluated at weekly intervals in three tests: motor activity habituation in the open field (30-min sessions at the same time on consecutive days), continuous spontaneous alternation in the Y-maze (8 min), and elevated plus-maze (5 min). Afterward, rats from the same litter were randomly assigned either to a caffeine-treated group ( n =13) or a control group ( n =11), which received only tap water. Caffeine treatment (5 mg/kg/day) began when animals were ≈4 months old, and lasted for 6 months. Behavioral tests were repeated from day 14 to day 28 after caffeine withdrawal, a time period that is far in excess for the full excretion of a caffeine dose in this species. Thirty days after caffeine discontinuation brains were processed for Golgi-Cox staining. Compared with controls, we found that middle-aged rats that had chronically consumed low doses of caffeine (1) maintained their locomotor habituation during the second consecutive day exposure to the open field (an index of non-associative learning), (2) maintained their exploratory drive to complete the conventional minimum of nine arm visits required to calculate the alternation performance in the Y-maze in a greater proportion, (3) maintained their alternation percentage above chance level (an index of working memory), and (4) did not increase the anxiety indexes assessed by measuring the time spent in the open arms of the elevated plus maze. In addition, morphometric analysis of hippocampal neurons revealed that dendritic branching (90–140 μm from the soma), length of 4th and 5th order branches, total dendritic length, and spine density in distal dendritic branches were greater in the basal but not the apical dendrites of CA1 pyramidal neurons from rats chronically treated with caffeine, in comparison with their age- and littermate-matched controls. Altogether, the present findings strengthen the epidemiological observations suggesting that prolonged caffeine intake prevents the cognitive decline associated with aging, and open the possibility that this process could be mediated by promoting the growth of dendrites and spines in neurons of the adult mammalian brain.</description><identifier>ISSN: 0306-4522</identifier><identifier>EISSN: 1873-7544</identifier><identifier>DOI: 10.1016/j.neuroscience.2011.11.053</identifier><identifier>PMID: 22155266</identifier><identifier>CODEN: NRSCDN</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>aging ; Aging - physiology ; Animals ; Anxiety - chemically induced ; Anxiety - psychology ; Biological and medical sciences ; CA1 Region, Hippocampal - cytology ; CA1 Region, Hippocampal - drug effects ; CA1 Region, Hippocampal - ultrastructure ; caffeine ; Caffeine - pharmacology ; Central Nervous System Stimulants - pharmacology ; Cognition Disorders - prevention &amp; control ; Cognition Disorders - psychology ; Data Interpretation, Statistical ; Dendrites - drug effects ; Dendrites - ultrastructure ; dendritic growth ; Electrophysiological Phenomena - drug effects ; Exploratory Behavior - drug effects ; Fundamental and applied biological sciences. Psychology ; Learning - drug effects ; Male ; Maze Learning - drug effects ; Medical sciences ; memory ; Memory, Short-Term - drug effects ; methylxanthines ; Motor Activity - drug effects ; Movement - physiology ; Neurology ; Neurons - drug effects ; Neurons - ultrastructure ; Neuropharmacology ; neuroprotection ; Pharmacology. Drug treatments ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Rats ; Rats, Wistar ; Vertebrates: nervous system and sense organs</subject><ispartof>Neuroscience, 2012-01, Vol.202, p.384-395</ispartof><rights>IBRO</rights><rights>2011 IBRO</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-c158a60738522e1ccc7da26149f43729d214fd941f434942fbb9e073ed55e9793</citedby><cites>FETCH-LOGICAL-c464t-c158a60738522e1ccc7da26149f43729d214fd941f434942fbb9e073ed55e9793</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.neuroscience.2011.11.053$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25499506$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22155266$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vila-Luna, S</creatorcontrib><creatorcontrib>Cabrera-Isidoro, S</creatorcontrib><creatorcontrib>Vila-Luna, L</creatorcontrib><creatorcontrib>Juárez-Díaz, I</creatorcontrib><creatorcontrib>Bata-García, J.L</creatorcontrib><creatorcontrib>Alvarez-Cervera, F.J</creatorcontrib><creatorcontrib>Zapata-Vázquez, R.E</creatorcontrib><creatorcontrib>Arankowsky-Sandoval, G</creatorcontrib><creatorcontrib>Heredia-López, F</creatorcontrib><creatorcontrib>Flores, G</creatorcontrib><creatorcontrib>Góngora-Alfaro, J.L</creatorcontrib><title>Chronic caffeine consumption prevents cognitive decline from young to middle age in rats, and is associated with increased length, branching, and spine density of basal dendrites in CA1 hippocampal neurons</title><title>Neuroscience</title><addtitle>Neuroscience</addtitle><description>Abstract Chronic caffeine consumption has been inversely associated with the risk of developing dementia and Alzheimer's disease. Here we assessed whether chronic caffeine treatment prevents the behavioral and cognitive decline that male Wistar rats experience from young (≈3 months) to middle age (≈10 months). When animals were young they were evaluated at weekly intervals in three tests: motor activity habituation in the open field (30-min sessions at the same time on consecutive days), continuous spontaneous alternation in the Y-maze (8 min), and elevated plus-maze (5 min). Afterward, rats from the same litter were randomly assigned either to a caffeine-treated group ( n =13) or a control group ( n =11), which received only tap water. Caffeine treatment (5 mg/kg/day) began when animals were ≈4 months old, and lasted for 6 months. Behavioral tests were repeated from day 14 to day 28 after caffeine withdrawal, a time period that is far in excess for the full excretion of a caffeine dose in this species. Thirty days after caffeine discontinuation brains were processed for Golgi-Cox staining. Compared with controls, we found that middle-aged rats that had chronically consumed low doses of caffeine (1) maintained their locomotor habituation during the second consecutive day exposure to the open field (an index of non-associative learning), (2) maintained their exploratory drive to complete the conventional minimum of nine arm visits required to calculate the alternation performance in the Y-maze in a greater proportion, (3) maintained their alternation percentage above chance level (an index of working memory), and (4) did not increase the anxiety indexes assessed by measuring the time spent in the open arms of the elevated plus maze. In addition, morphometric analysis of hippocampal neurons revealed that dendritic branching (90–140 μm from the soma), length of 4th and 5th order branches, total dendritic length, and spine density in distal dendritic branches were greater in the basal but not the apical dendrites of CA1 pyramidal neurons from rats chronically treated with caffeine, in comparison with their age- and littermate-matched controls. Altogether, the present findings strengthen the epidemiological observations suggesting that prolonged caffeine intake prevents the cognitive decline associated with aging, and open the possibility that this process could be mediated by promoting the growth of dendrites and spines in neurons of the adult mammalian brain.</description><subject>aging</subject><subject>Aging - physiology</subject><subject>Animals</subject><subject>Anxiety - chemically induced</subject><subject>Anxiety - psychology</subject><subject>Biological and medical sciences</subject><subject>CA1 Region, Hippocampal - cytology</subject><subject>CA1 Region, Hippocampal - drug effects</subject><subject>CA1 Region, Hippocampal - ultrastructure</subject><subject>caffeine</subject><subject>Caffeine - pharmacology</subject><subject>Central Nervous System Stimulants - pharmacology</subject><subject>Cognition Disorders - prevention &amp; control</subject><subject>Cognition Disorders - psychology</subject><subject>Data Interpretation, Statistical</subject><subject>Dendrites - drug effects</subject><subject>Dendrites - ultrastructure</subject><subject>dendritic growth</subject><subject>Electrophysiological Phenomena - drug effects</subject><subject>Exploratory Behavior - drug effects</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Learning - drug effects</subject><subject>Male</subject><subject>Maze Learning - drug effects</subject><subject>Medical sciences</subject><subject>memory</subject><subject>Memory, Short-Term - drug effects</subject><subject>methylxanthines</subject><subject>Motor Activity - drug effects</subject><subject>Movement - physiology</subject><subject>Neurology</subject><subject>Neurons - drug effects</subject><subject>Neurons - ultrastructure</subject><subject>Neuropharmacology</subject><subject>neuroprotection</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Vertebrates: nervous system and sense organs</subject><issn>0306-4522</issn><issn>1873-7544</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkl2rEzEQhhdRPMejf0GCIN6c1iSb7Ha9EA71Ew54oV6HNJltU3eTNZOt9Ef6n0xs_cArQyBM8sxMeN-pqieMLhllzfP90sMcAxoH3sCSU8aWeVNZ36ku2aqtF60U4m51SWvaLITk_KJ6gLineUlR368uOGdS8qa5rL6vdzF4Z4jRfQ_OAzHB4zxOyQVPpggH8Anz5da75A5ALJihYH0MIzmG2W9JCmR01g5A9BaI8yTqhNdEe0scEo0YjNMJLPnm0i6_mwgacziA36bdNdlE7c3O-e0pB6dS34JHl44k9GSjUQ_lwkaXAEuH9Q0jOzdNwehxyo8_BfH4sLrX6wHh0fm8qj6_ef1p_W5x--Ht-_XN7cKIRqSFYXKlG9rWq6wNMGNMazVvmOh6Ube8s5yJ3naC5VB0gvebTQcZBysldG1XX1XPTnWnGL7OgEmNDg0Mg_YQZlQdW3W1pHWbyRcn0mTDMEKvpuhGHY-KUVXcVHv1t5uquKnyzm7m5MfnNvNmBPs79Zd9GXh6BjQaPfRFSId_OCm6TtLCvTpxkEU5OIjq3M66CCYpG9z__eflP2XKLLjc-QscAfdhjj7LrphCrqj6WOavjB_LhWuR__ED6Xvdag</recordid><startdate>20120127</startdate><enddate>20120127</enddate><creator>Vila-Luna, S</creator><creator>Cabrera-Isidoro, S</creator><creator>Vila-Luna, L</creator><creator>Juárez-Díaz, I</creator><creator>Bata-García, J.L</creator><creator>Alvarez-Cervera, F.J</creator><creator>Zapata-Vázquez, R.E</creator><creator>Arankowsky-Sandoval, G</creator><creator>Heredia-López, F</creator><creator>Flores, G</creator><creator>Góngora-Alfaro, J.L</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120127</creationdate><title>Chronic caffeine consumption prevents cognitive decline from young to middle age in rats, and is associated with increased length, branching, and spine density of basal dendrites in CA1 hippocampal neurons</title><author>Vila-Luna, S ; Cabrera-Isidoro, S ; Vila-Luna, L ; Juárez-Díaz, I ; Bata-García, J.L ; Alvarez-Cervera, F.J ; Zapata-Vázquez, R.E ; Arankowsky-Sandoval, G ; Heredia-López, F ; Flores, G ; Góngora-Alfaro, J.L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-c158a60738522e1ccc7da26149f43729d214fd941f434942fbb9e073ed55e9793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>aging</topic><topic>Aging - physiology</topic><topic>Animals</topic><topic>Anxiety - chemically induced</topic><topic>Anxiety - psychology</topic><topic>Biological and medical sciences</topic><topic>CA1 Region, Hippocampal - cytology</topic><topic>CA1 Region, Hippocampal - drug effects</topic><topic>CA1 Region, Hippocampal - ultrastructure</topic><topic>caffeine</topic><topic>Caffeine - pharmacology</topic><topic>Central Nervous System Stimulants - pharmacology</topic><topic>Cognition Disorders - prevention &amp; control</topic><topic>Cognition Disorders - psychology</topic><topic>Data Interpretation, Statistical</topic><topic>Dendrites - drug effects</topic><topic>Dendrites - ultrastructure</topic><topic>dendritic growth</topic><topic>Electrophysiological Phenomena - drug effects</topic><topic>Exploratory Behavior - drug effects</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Learning - drug effects</topic><topic>Male</topic><topic>Maze Learning - drug effects</topic><topic>Medical sciences</topic><topic>memory</topic><topic>Memory, Short-Term - drug effects</topic><topic>methylxanthines</topic><topic>Motor Activity - drug effects</topic><topic>Movement - physiology</topic><topic>Neurology</topic><topic>Neurons - drug effects</topic><topic>Neurons - ultrastructure</topic><topic>Neuropharmacology</topic><topic>neuroprotection</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Vertebrates: nervous system and sense organs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vila-Luna, S</creatorcontrib><creatorcontrib>Cabrera-Isidoro, S</creatorcontrib><creatorcontrib>Vila-Luna, L</creatorcontrib><creatorcontrib>Juárez-Díaz, I</creatorcontrib><creatorcontrib>Bata-García, J.L</creatorcontrib><creatorcontrib>Alvarez-Cervera, F.J</creatorcontrib><creatorcontrib>Zapata-Vázquez, R.E</creatorcontrib><creatorcontrib>Arankowsky-Sandoval, G</creatorcontrib><creatorcontrib>Heredia-López, F</creatorcontrib><creatorcontrib>Flores, G</creatorcontrib><creatorcontrib>Góngora-Alfaro, J.L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vila-Luna, S</au><au>Cabrera-Isidoro, S</au><au>Vila-Luna, L</au><au>Juárez-Díaz, I</au><au>Bata-García, J.L</au><au>Alvarez-Cervera, F.J</au><au>Zapata-Vázquez, R.E</au><au>Arankowsky-Sandoval, G</au><au>Heredia-López, F</au><au>Flores, G</au><au>Góngora-Alfaro, J.L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chronic caffeine consumption prevents cognitive decline from young to middle age in rats, and is associated with increased length, branching, and spine density of basal dendrites in CA1 hippocampal neurons</atitle><jtitle>Neuroscience</jtitle><addtitle>Neuroscience</addtitle><date>2012-01-27</date><risdate>2012</risdate><volume>202</volume><spage>384</spage><epage>395</epage><pages>384-395</pages><issn>0306-4522</issn><eissn>1873-7544</eissn><coden>NRSCDN</coden><abstract>Abstract Chronic caffeine consumption has been inversely associated with the risk of developing dementia and Alzheimer's disease. Here we assessed whether chronic caffeine treatment prevents the behavioral and cognitive decline that male Wistar rats experience from young (≈3 months) to middle age (≈10 months). When animals were young they were evaluated at weekly intervals in three tests: motor activity habituation in the open field (30-min sessions at the same time on consecutive days), continuous spontaneous alternation in the Y-maze (8 min), and elevated plus-maze (5 min). Afterward, rats from the same litter were randomly assigned either to a caffeine-treated group ( n =13) or a control group ( n =11), which received only tap water. Caffeine treatment (5 mg/kg/day) began when animals were ≈4 months old, and lasted for 6 months. Behavioral tests were repeated from day 14 to day 28 after caffeine withdrawal, a time period that is far in excess for the full excretion of a caffeine dose in this species. Thirty days after caffeine discontinuation brains were processed for Golgi-Cox staining. Compared with controls, we found that middle-aged rats that had chronically consumed low doses of caffeine (1) maintained their locomotor habituation during the second consecutive day exposure to the open field (an index of non-associative learning), (2) maintained their exploratory drive to complete the conventional minimum of nine arm visits required to calculate the alternation performance in the Y-maze in a greater proportion, (3) maintained their alternation percentage above chance level (an index of working memory), and (4) did not increase the anxiety indexes assessed by measuring the time spent in the open arms of the elevated plus maze. In addition, morphometric analysis of hippocampal neurons revealed that dendritic branching (90–140 μm from the soma), length of 4th and 5th order branches, total dendritic length, and spine density in distal dendritic branches were greater in the basal but not the apical dendrites of CA1 pyramidal neurons from rats chronically treated with caffeine, in comparison with their age- and littermate-matched controls. Altogether, the present findings strengthen the epidemiological observations suggesting that prolonged caffeine intake prevents the cognitive decline associated with aging, and open the possibility that this process could be mediated by promoting the growth of dendrites and spines in neurons of the adult mammalian brain.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>22155266</pmid><doi>10.1016/j.neuroscience.2011.11.053</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0306-4522
ispartof Neuroscience, 2012-01, Vol.202, p.384-395
issn 0306-4522
1873-7544
language eng
recordid cdi_proquest_miscellaneous_918935037
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects aging
Aging - physiology
Animals
Anxiety - chemically induced
Anxiety - psychology
Biological and medical sciences
CA1 Region, Hippocampal - cytology
CA1 Region, Hippocampal - drug effects
CA1 Region, Hippocampal - ultrastructure
caffeine
Caffeine - pharmacology
Central Nervous System Stimulants - pharmacology
Cognition Disorders - prevention & control
Cognition Disorders - psychology
Data Interpretation, Statistical
Dendrites - drug effects
Dendrites - ultrastructure
dendritic growth
Electrophysiological Phenomena - drug effects
Exploratory Behavior - drug effects
Fundamental and applied biological sciences. Psychology
Learning - drug effects
Male
Maze Learning - drug effects
Medical sciences
memory
Memory, Short-Term - drug effects
methylxanthines
Motor Activity - drug effects
Movement - physiology
Neurology
Neurons - drug effects
Neurons - ultrastructure
Neuropharmacology
neuroprotection
Pharmacology. Drug treatments
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopharmacology
Rats
Rats, Wistar
Vertebrates: nervous system and sense organs
title Chronic caffeine consumption prevents cognitive decline from young to middle age in rats, and is associated with increased length, branching, and spine density of basal dendrites in CA1 hippocampal neurons
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T10%3A17%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chronic%20caffeine%20consumption%20prevents%20cognitive%20decline%20from%20young%20to%20middle%20age%20in%20rats,%20and%20is%20associated%20with%20increased%20length,%20branching,%20and%20spine%20density%20of%20basal%20dendrites%20in%20CA1%20hippocampal%20neurons&rft.jtitle=Neuroscience&rft.au=Vila-Luna,%20S&rft.date=2012-01-27&rft.volume=202&rft.spage=384&rft.epage=395&rft.pages=384-395&rft.issn=0306-4522&rft.eissn=1873-7544&rft.coden=NRSCDN&rft_id=info:doi/10.1016/j.neuroscience.2011.11.053&rft_dat=%3Cproquest_cross%3E918935037%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=918935037&rft_id=info:pmid/22155266&rft_els_id=1_s2_0_S0306452211013406&rfr_iscdi=true